News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Endurance Bio Inc. Announces Selection of T-168 for Neuro-SysMed’s SLEIPNIR Platform Trial in Parkinson’s Disease
Friday, May 23, 2025Endurance Bio Inc a clinicalstage biotechnology company developing therapies for neurodegenerative and metabolic diseases today announced that its compound T has been selected for testing on the SLEIPNIR clinical trial platform for Parkinsons disease...
OSE Immunotherapeutics Announces Strategic Collaboration to Pioneer Novel mRNA Technologies
Thursday, May 22, 2025OSE Immunotherapeutics SA today announces a strategic collaboration with AngoulmeBordeaux based Inside Therapeutics and Angersbased MiNT Laboratory to develop mRNA therapeutics and accelerate nanodrug development OSE Immunotherapeutics has received...
Sandoz launches Pyzchiva® autoinjector, first commercially available in Europe for ustekinumab biosimilars
Thursday, May 22, 2025Sandoz the global leader in generic and biosimilar medicines today announced the European launch of its Pyzchiva ustekinumab autoinjector This is the first ustekinumab biosimilar in Europe commercially available in an autoinjector Developed and regis...
Tubulis Achieves Key Milestone in BMS Strategic License Agreement as First Collaboration Tubutecan ADC Enters the Clinic
Wednesday, May 21, 2025Tubulis today announced that the first program from its strategic license agreement with Bristol Myers Squibb has entered clinical development triggering a significant milestone in the ongoing collaboration
Orion’s collaborator, MSD, expands clinical development program for opevesostat to women’s cancers
Wednesday, May 21, 2025Orions collaborator MSD has expanded the development program for opevestostat MK to now include womens cancers A new Phase clinical trial evaluating the safety and efficacy of opevesostat for the treatment of breast
Cellino’s iPSC Biomanufacturing Technology Receives FDA Advanced Manufacturing Technology Designation
Tuesday, May 20, 2025Cellino has received recognition from the US Food and Drug Administration FDA for its optical biomanufacturing technology used in the production of induced pluripotent stem cells iPSCs The companys platform has been granted
Novavax Gains U.S. FDA Approval for COVID-19 Vaccine
Tuesday, May 20, 2025Novavax Inc has received approval from the US Food and Drug Administration FDA for its Biologics License Application BLA for Nuvaxovid a proteinbased COVID vaccine The approval covers use in adults aged and above
IQVIA and SCRI Partner to Speed Up Global Cancer Trials
Saturday, May 17, 2025IQVIA a global leader in clinical research and healthcare intelligence has entered into a strategic partnership with SCRI Development Innovations the clinical research division of the Sarah Cannon Research Institute
PharmAla Biotech Introduces Phenesafe AI Platform for Discovery of Novel Phenethylamine Compounds
Friday, May 16, 2025PharmAla Biotech Holdings Inc a biotechnology firm dedicated to the research development and manufacturing of LaNeo MDMA and new derivatives within the MDXX compound class has officially launched its Phenesafe AI platform
Intelligent Bio Solutions Drives Global Growth of Fingerprint-Based Drug Testing
Friday, May 16, 2025Intelligent Bio Solutions Inc a medical technology company offering rapid noninvasive testing solutions has reported recent progress in expanding its global presence Growth has been driven by new client acquisitions
